午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
In the first half of the year, nine prices of Chinese medicinal materials are expected to be raised
 
Author:中國銘鉉 企劃部  Release Time:2017-7-25 10:31:24  Number Browse:631
 
Medical website on July 25 
 
1. Raspberry (products of zhejiang province) 
 
[prices] rose to 300 yuan in June from 275 yuan at the beginning of this year. 
 
[analysis] raspberry is a small breed, producing area is relatively concentrated, annual output is affected by the weather, this year, output and is flat production conditions, and the inventory to a minimum in recent years, and the goods supply more concentrated in the hands of several large of origin, is expected to actual after digestion with market is expected to be positive. 
 
2. Fat sea (imported, round fruit) 
 
[price] rose from 55 yuan at the beginning of this year to 85 yuan in June. 
 
In recent years, the price has fluctuated greatly. The highest price in the first half of 2014 rose to 220 yuan, and the lowest price in October was about 40 yuan. From 2015 to February 2017, the price of the fat sea fluctuates more than 55 yuan. This year, the fruit production is low and the price is steadily climbing. 
 
Chubby sea comes in two seasons a year. Spring fruit comes in april-may, and autumn fruit comes from July to August. It is not far from the autumn fruit production, and this autumn fruit production will determine the next price fluctuation. 
 
3. Five flavors of liao (northeast, united cargo) 
 
[price] rose from 125 yuan at the beginning of the year to 155 yuan in June. 
 
[analysis] the variety cultivation during the period of high plant provinces has already taken place, and in a few years ago at a low price when the majority of the plants have been cut down, lead to production in recent years, and have a big money involved, since the second half of last year to power up again, enter the rally in 2017. 
 
Since the price of the five flavors of liao has increased greatly in the near half year, the supply of goods in the hands of retail investors has been sold off, and this year's flowering period has been hit by the freezing damage, and there has been a positive result of the production cut, which is expected to be difficult to calm down in the future. 
 
4. Shrub jingzi (jiangxi province, united cargo) 
 
[prices] rose from 150 yuan in January to 180 yuan in June. 
 
[analysis] the variety price rise last two years, in the first half of 2016 the price also in 55 yuan (production in jiangxi, gradeless and uniformly priced goods) wander up and down, in the second half of the price rose to 90 yuan of above, at the end of the year rose to 130 yuan, to further into the 2017 rally is still unabated. 
 
There are also a small number of imports in jiangxi, yunnan, guangxi and other places, among which the content of the flavin in jiangxi is the highest, while the content of yunnan and other places is lower than the standard of pharmacopoeia. After the implementation of the 2015 edition of the pharmacopoeia, the sales of zhengpin cranjingzi increased, and the price increased. Spurred by skyrocketing prices, the company has begun artificial cultivation and is expected to increase production this year, and the price is expected to fall after new production. 
 
5. Wu zhuyu (jiangxi province, zhong hua) 
 
[price] rose from 280 yuan in January to 380 yuan in June. 
 
[analysis] the price of wu zhuyu has been running for more than a year in 2015 due to the backlogs of the previous years. As the market actually digests, the inventory keeps decreasing, and the price of wu zhuyu rose to about 130 yuan in March 2016. 
 
Although in recent years, there have been the expansion of cultivation of medicinal plants, but wu zhuyu will need three to five years of fruit production after planting, and the production of new goods will remain small in 2016. In 2017, the supply of wu zhuyu is very tight, and the price has been rising steadily under the actual demand of the market. It is expected to be a bumper harvest this year, with prices expected to fall after the new harvest. 
 
6. Huanglian (sichuan, chicken feet) 
 
[price] the variety has not risen much, from 100 yuan in January to 110 yuan in June. 
 
[analysis] every step of the price of the huanglian price has been affected by Chen goods. Although there are a lot of businesses bullish on the future trend, it is still necessary to continue to absorb the solid foundation of the inventory in the short term. 
 
7. Dogwood (henan, united cargo) 
 
[price] rose from 27 yuan in January to 38 yuan in June. 
 
[analysis] dogwood flowering snow this year suffered from frost damage, future production may be affected, many businessmen bullish on the future, since the flowering has business purchase quietly to rise unceasingly, pull the prices to rise. Still, inventories are still the biggest stumbling block on prices. 
 
8. Stone calamus (anhui province, united cargo) 
 
[prices] rose from 37 yuan at the beginning of the year to 50 yuan in June. 
 
[analysis] the strains in the wild, due to the price in 32 yuan wander up and down a few years ago, herbalist excavation of enthusiasm is not high, merchants backlog digest more old stock, its wild resources and the break is less, production has been less this year, prices climbed steadily. As the price increases in the short term, the market will need to be adjusted. 
 
9. Yunmu xiang (yunnan province, united cargo) 
 
[price] rose from 13.5 yuan in January to 17 yuan in June. 
 
[analysis] the price of cloud wood has risen steadily since January, mainly because the market is not very good. The price of this species has been hovering within 10 yuan for the previous years, and the enthusiasm of the drug growers is not high, resulting in the decline in production, and the future price is expected to increase with the further decrease of market supply. 
 
Previous article:The whole process of reviewing and approving the examination and approval system of medical device for medical devices is reviewed
Next article:Medical insurance + new product approved by the DPP - 4 drug acceleration
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網(wǎng)安備 44011202000029號(hào)